Better Therapeutics, Inc. (BTTX) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 78 transactions totaling $10.1M, demonstrating a bullish sentiment with $10.1M in net insider flow. The most recent transaction on Feb 9, 2024 involved a transaction of 839,895 shares valued at $159.6K.
No significant insider buying has been recorded for BTTX in the recent period.
No significant insider selling has been recorded for BTTX in the recent period.
Based on recent SEC filings, insider sentiment for BTTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $10.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Better Therapeutics, Inc. (BTTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading BTTX stock, having executed 78 transactions in the past 90 days. The most active insider is P. Perry 2015 Trust David (Executive), who has made 16 transactions totaling $7.7M.
Get notified when executives and directors at BTTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 9, 2024 | P. Perry David | Executive | Award | 839,895 | $0.19 | $159.6K | |
| Jan 9, 2024 | P. Perry David | Executive | Award | 1,471,453 | $0.17 | $250.1K | |
| Dec 18, 2023 | A. Berman Mark | Executive | Award | 25,362 | $N/A | $0 | |
| Dec 18, 2023 | Karbe Frank | Executive | Award | 62,500 | $N/A | $0 | |
| Dec 18, 2023 | Granger Elder | Executive | Award | 3,750 | $N/A | $0 | |
| Dec 18, 2023 | A. Miller Leslie | Executive | Award | 3,587 | $N/A | $0 | 10b5-1 |
| Dec 18, 2023 | J. Armanino Andrew | Executive | Award | 3,750 | $N/A | $0 | |
| Dec 18, 2023 | M. Parker Geoffrey | Executive | Award | 3,750 | $N/A | $0 | |
| Dec 18, 2023 | Wynholds Kristin | Executive | Award | 25,362 | $N/A | $0 | |
| Dec 18, 2023 | J. Lavizzo-mourey Risa | Executive | Award | 3,750 | $N/A | $0 | |
| Dec 18, 2023 | H. Carmona Richard | Executive | Award | 3,750 | $N/A | $0 | |
| Dec 18, 2023 | P. Perry David | Executive | Award | 3,750 | $N/A | $0 | |
| Jul 27, 2023 | M. Parker Geoffrey | Executive | Purchase | 685,025 | $0.73 | $500.1K | Large |
| Jul 27, 2023 | Karbe Frank | Executive | Purchase | 137,005 | $0.73 | $100.0K | |
| Jul 27, 2023 | Granger Elder | Executive | Purchase | 34,251 | $0.73 | $25.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 47 | $10.1M | 87.3% |
Award(A) | 27 | $1.4M | 12.5% |
Exercise(M) | 2 | $18.5K | 0.2% |
Other(J) | 2 | $0 | 0.0% |
Insiders at Better Therapeutics, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 78 transactions totaling $10.1M in purchases versus $0 in sales, the net buying activity of $10.1M signals strong executive confidence. P. Perry 2015 Trust David (Executive) leads the buying activity with $7.7M in transactions across all time.